PANews reported on October 22nd that, according to Businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced the completion of its previously announced private investment in equity (PIPE) financing led by institutional DeFi and TradFi investors, with initial BNB holdings valued at over $17 million. The PIPE generated approximately $27 million in gross proceeds for the company, with the potential for up to $31 million in additional gross proceeds from future warrant exercises. The total proceeds from the PIPE transaction included $15.3 million in cash and stablecoins, as well as $11.71 million in BNB trust units. The company received a total of 435,638 trust units, representing underlying ownership of 10,647 BNB tokens. The company also announced today that it has purchased an additional 4,908 BNB tokens, with an estimated total value of $5.3 million as of 10:00 PM ET on October 20, 2025.PANews reported on October 22nd that, according to Businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced the completion of its previously announced private investment in equity (PIPE) financing led by institutional DeFi and TradFi investors, with initial BNB holdings valued at over $17 million. The PIPE generated approximately $27 million in gross proceeds for the company, with the potential for up to $31 million in additional gross proceeds from future warrant exercises. The total proceeds from the PIPE transaction included $15.3 million in cash and stablecoins, as well as $11.71 million in BNB trust units. The company received a total of 435,638 trust units, representing underlying ownership of 10,647 BNB tokens. The company also announced today that it has purchased an additional 4,908 BNB tokens, with an estimated total value of $5.3 million as of 10:00 PM ET on October 20, 2025.